Cicone F - Search Results

1

Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.

Cicone F, Minniti G, Romano A, Papa A, Scaringi C, Tavanti F, Bozzao A, Maurizi Enrici R, Scopinaro F. Cicone F, et al. Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):103-11. doi: 10.1007/s00259-014-2886-4. Epub 2014 Aug 15. Eur J Nucl Med Mol Imaging. 2015. PMID: 25182751

2

¹⁸F-PSMA-1007 salivary gland dosimetry: comparison between different methods for dose calculation and assessment of inter- and intra-patient variability.

Pistone D, Gnesin S, Auditore L, Italiano A, Cascini GL, Amato E, Cicone F. Pistone D, et al. Among authors: cicone f. Phys Med Biol. 2023 Apr 7;68(8). doi: 10.1088/1361-6560/acc633. Phys Med Biol. 2023. PMID: 36944252

3

Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck.

Cicone F, Loose D, Deron P, Vermeersch H, Signore A, Van de Vyvere F, Scopinaro F, Van de Wiele C. Cicone F, et al. Nucl Med Commun. 2008 May;29(5):431-5. doi: 10.1097/MNM.0b013e3282f5d2ce. Nucl Med Commun. 2008. PMID: 18391726

4

Studying the metabolic activity of red bone marrow by means of FDG-PET: the need for a standardization.

Cicone F, Signore A, Scopinaro F. Cicone F, et al. Mol Imaging Biol. 2008 May-Jun;10(3):129-30. doi: 10.1007/s11307-008-0138-3. Epub 2008 Apr 18. Mol Imaging Biol. 2008. PMID: 18421505 No abstract available.

5

Tc-99m DTPA cisternography shows disappearance of cerebrospinal fluid leakage after standing a short time.

Del Mastro C, Cicone F, D'Andrea G, Scopinaro F. Del Mastro C, et al. Among authors: cicone f. Clin Nucl Med. 2009 Jan;34(1):29-30. doi: 10.1097/RLU.0b013e31818f446e. Clin Nucl Med. 2009. PMID: 19092380 No abstract available.

6

Radioimmunotherapy of heavily pre-treated, non-Hodgkin's lymphoma patients: efficacy and safety in a routine setting.

Cicone F, Baldini R, Cox MC, Russo E, Torelli F, Tofani A, Scopinaro F. Cicone F, et al. Anticancer Res. 2009 Nov;29(11):4771-7. Anticancer Res. 2009. PMID: 20032434 Free article.

7

A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with (90)Y-ibritumomab tiuxetan (Zevalin).

Pacilio M, Betti M, Cicone F, Del Mastro C, Montani L, Chiacchiararelli L, Monaco A, Santini E, Scopinaro F. Pacilio M, et al. Among authors: cicone f. Eur J Nucl Med Mol Imaging. 2010 May;37(5):862-73. doi: 10.1007/s00259-009-1333-4. Epub 2010 Jan 13. Eur J Nucl Med Mol Imaging. 2010. PMID: 20069297

8

Follicular lymphoma at relapse after rituximab containing regimens: comparison of time to event intervals prior to and after 90 Y-ibritumomab-tiuxetan.

Cicone F, Russo E, Carpaneto A, Prior JO, Delaloye AB, Scopinaro F, Ketterer N. Cicone F, et al. Hematol Oncol. 2011 Sep;29(3):131-8. doi: 10.1002/hon.968. Epub 2010 Sep 22. Hematol Oncol. 2011. PMID: 20862654

9

Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan.

D'Arienzo M, Cicone F, Chiacchiararelli L, Coniglio A, Delaloye AB, Scopinaro F. D'Arienzo M, et al. Among authors: cicone f. Cancer Biother Radiopharm. 2012 Mar;27(2):124-33. doi: 10.1089/cbr.2011.1063. Epub 2012 Jan 27. Cancer Biother Radiopharm. 2012. PMID: 22283680

10

Fatal pulmonary tumour thrombotic microangiopathy: do typical FDG-PET findings exist?

Cicone F, Del Forno M, Papa A, Comito F, Festa A, Uccini S, Scopinaro F. Cicone F, et al. Nuklearmedizin. 2012;51(1):N6-9. Nuklearmedizin. 2012. PMID: 22337255 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters